Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |